The Cigna Group raised its 2026 adjusted earnings outlook after third-quarter revenue rose 6%, while pharmacy benefit pressure kept underlying profit broadly flat. The health insurer also unveiled a US$3 billion modernisation and productivity programme targeting longer-term growth.
Adherium reports strong patient adoption and new US partnerships, positioning for significant expansion in 2025 with a target of 9,000 active users and entry into the Pharmacy Benefit Management sector.